newsfilter
← Latest News
GlobeNewswire·

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor "What This Means" Segment

Watch the "What This Means" video here Featuring the Company's pembrolizumab-based immune checkpoint inhibitor MIRAMAR, Fla., Oct. 22, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the "Company" or "HCW